Neuroone Medical Technologies (NMTC) Cash from Investing Activities (2017 - 2026)
Neuroone Medical Technologies (NMTC) reported Cash from Investing Activities of -$38516.0 for Q1 2026, down 1114.63% year-over-year from $3796.1 in Q1 2025, and up 5.49% sequentially from -$40754.0 in Q4 2025.
Neuroone Medical Technologies (NMTC) Cash from Investing Activities (2017 - 2026) Analysis & Trends
Neuroone Medical Technologies has disclosed Cash from Investing Activities across 10 years of filings, most recently posting -$38516.0 for Q1 2026.
- Quarterly Cash from Investing Activities fell 1114.63% year-over-year to -$38516.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$133425.0 (down 68.27% YoY) and the FY2025 annual result came in at -$81742.0, up 31.99% from the prior year.
- Cash from Investing Activities climbed to -$38516.0 in Q1 2026, from -$40754.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $1.8 million in Q1 2023 and bottomed at -$3.0 million in Q3 2022.
- The 5-year median for Cash from Investing Activities is -$36905.0 (2024), against an average of -$47912.9.
- Year-over-year, Cash from Investing Activities slumped 8546.56% in 2022 and jumped 2054.91% in 2023.
- Neuroone Medical Technologies' Cash from Investing Activities stood at $15069.0 in 2022, then tumbled by 346.41% to -$37131.0 in 2023, then jumped by 34.24% to -$24416.0 in 2024, then slumped by 66.92% to -$40754.0 in 2025, then gained by 5.49% to -$38516.0 in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$38516.0, -$40754.0, and -$10607.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -298.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -2.50 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -217.20 Mn |
| 10 | Neuroone Medical Technologies | 26.73 Mn | 23.93 Mn | 990,264.00 | -38,516.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -38,516.00 |
| Mar 31, 2026 | -38,516.00 |
| Dec 31, 2025 | -40,754.00 |
| Dec 31, 2025 | -40,754.00 |
| Sep 30, 2025 | -10,607.00 |
| Sep 30, 2025 | -10,607.00 |
| Jun 30, 2025 | -43,548.00 |
| Jun 30, 2025 | -43,548.00 |
| Mar 31, 2025 | -3,171.00 |
| Mar 31, 2025 | -3,171.00 |
| Dec 31, 2024 | -24,416.00 |
| Dec 31, 2024 | -24,416.00 |
| Sep 30, 2024 | -36,905.00 |
| Sep 30, 2024 | -36,905.00 |
| Jun 30, 2024 | -14,801.00 |
| Jun 30, 2024 | -14,801.00 |
| Mar 31, 2024 | -31,360.00 |
| Mar 31, 2024 | -31,360.00 |
| Dec 31, 2023 | -37,131.00 |
| Dec 31, 2023 | -37,131.00 |